Perimeter Medical Imaging AI Inc (OTCPK:PYNKF)

$ 0.3545 -0.0305 (-7.92%) Market Cap: 32.66 Mil Enterprise Value: 23.29 Mil PE Ratio: 0 PB Ratio: 2.53 GF Score: 36/100

Q3 2024 Perimeter Medical Imaging AI Inc Earnings Call Transcript
Nov 14, 2024

$0.3235 (+3.39%)

Earnings
Q2 2024 Perimeter Medical Imaging AI Inc Earnings Call Transcript
Aug 14, 2024

$0.2882 (-9.99%)

Earnings
Q1 2024 Perimeter Medical Imaging AI Inc Earnings Call Transcript
May 14, 2024

$0.42025 (-1.58%)

Earnings
Q4 2023 Perimeter Medical Imaging AI Inc Earnings Call Transcript
Mar 28, 2024

$0.6454

Earnings
Perimeter Medical Imaging AI Inc Investor Webinar Transcript
Nov 30, 2023
Q3 2023 Perimeter Medical Imaging AI Inc Earnings Call Transcript
Nov 14, 2023

$0.6

Earnings
Perimeter Medical Imaging AI Inc Investor Webcast Transcript
Oct 25, 2023
Q2 2023 Perimeter Medical Imaging AI Inc Earnings Call Transcript
Aug 29, 2023

$1.09

Earnings
Q1 2023 Perimeter Medical Imaging AI Inc Earnings Call Transcript
May 25, 2023

$1.35 (-2.53%)

Earnings
Perimeter Medical Imaging AI Inc at Bloom Burton & Co Healthcare Investor Conference Transcript
Apr 26, 2023
Q4 2022 Perimeter Medical Imaging AI Inc Earnings Call Transcript
Apr 11, 2023

$1.25 (-0.60%)

Earnings
Q3 2022 Perimeter Medical Imaging AI Inc Earnings Call Transcript
Nov 15, 2022

$1.08 (-0.91%)

Earnings
Q2 2022 Perimeter Medical Imaging AI Inc Earnings Call Transcript
Aug 24, 2022

$1.39 (-0.88%)

Earnings
Q1 2022 Perimeter Medical Imaging AI Inc Earnings Call Transcript
Jun 01, 2022

$1.72 (+13.16%)

Earnings
Q4 2021 Perimeter Medical Imaging AI Inc Earnings Call Transcript
May 03, 2022

$1.95 (+2.63%)

Earnings
Perimeter Medical Imaging AI Inc at Bloom Burton & Co. Healthcare Investor Conference Transcript
May 02, 2022
Perimeter Medical Imaging AI Inc at Noble Capital Markets Investor Conference (Virtual) Transcript
Apr 19, 2022
Perimeter Medical Imaging AI Inc at Lytham Partners Fall Investor Conference (Virtual) Transcript
Oct 05, 2021

Q2 2024 Perimeter Medical Imaging AI Inc Earnings Call Transcript

Aug 14, 2024 / 09:00PM GMT

Release Date Price: $0.2882 (-9.99%)

Transcript

Operator

Good afternoon, ladies and gentlemen, and welcome to the Perimeter Medical Q2 2024 conference call. (Operator Instructions) This call is being recorded on Wednesday, August 13, 2024.

I would now like to turn the conference over to Stephen Kilmer, Investor Relations. Please go ahead.

Stephen Kilmer

Perimeter Medical Imaging AI - Investor Relations

Thank you. Good afternoon, everyone. Let me start out by pointing out that this conference call will include forward-looking statements within the meaning of applicable securities laws. These may include statements regarding the future financial position, business strategy and strategic goals; commercial activities and timing; competitive conditions; research and development activities; projected costs and capital expenditures; research and clinical testing outcomes; the potential benefits of our products, including Perimeter S-Series OCT, Perimeter B-Series OCT, and Perimeter ImgAssist; Perimeter's ability to broaden its user base and the expected approval of its proprietary AI; expectations regarding new

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.